Tower Research Capital LLC (TRC) - QUALIGEN THERAPEUTICS INC ownership

QUALIGEN THERAPEUTICS INC's ticker is and the CUSIP is 74754R202. A total of 20 filers reported holding QUALIGEN THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of QUALIGEN THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$1,042
-57.2%
6,058
-0.5%
0.00%
Q1 2024$2,435
-15.8%
6,087
+15.7%
0.00%
Q4 2023$2,893
-42.2%
5,260
+6.2%
0.00%
Q3 2023$5,005
+19.2%
4,955
+7.5%
0.00%
Q2 2023$4,199
+209850.0%
4,609
+132.5%
0.00%
Q1 2023$21,9820.00%
Other shareholders
QUALIGEN THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
HighMark Wealth Management LLC 8,009$7,4090.01%
US BANCORP \DE\ 824$7620.00%
WELLS FARGO & COMPANY/MN 29$270.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
UBS Group AG 11,277$10,4310.00%
Retirement Group, LLC 350$00.00%
Archer Investment Corp 16$150.00%
GEODE CAPITAL MANAGEMENT, LLC 22,329$20,6580.00%
BlackRock Inc. 25,840$23,9050.00%
ICA Group Wealth Management, LLC 245$2270.00%
View complete list of QUALIGEN THERAPEUTICS INC shareholders